Junhang Luo

4PUBLICATIONS
9CO-AUTHORS
Tumour immunologyMechanobiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 06, 2026
Soluble HER2 promotes chronic antigen-mediated CD8⁺ T-cell dysfunction and limits immunotherapy response in HER2-low triple-negative breast cancer.

|Dec 13, 2024
Methionine-driven YTHDF1 expression facilitates bladder cancer progression by attenuating RIG-I-modulated immune responses and enhancing the eIF5B-PD-L1 axis.

Anze Yu, Liangmin Fu, Lanyu Jing

|Jan 05, 2024
Continuous Expression of Interferon Regulatory Factor 4 Sustains CD8<sup>+</sup> T Cell Immunity against Tumor.

Anze Yu, Jinfei Fu, Zheng Yin

|Jun 28, 2023
MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria-dependent dephosphorylation of EGFR.

Li Luo, Denghui Wei, Yihui Pan

Pageof 1

Frequent Collaborators

1 joint publications

Wenhao Chen

1 joint publications

Liangmin Fu

1 joint publications

Yinghan Wang

1 joint publications

Zhenhua Chen